North America Drug Delivery Market are rising prevalence of chronic disease such as diabetes, growth of biologics, new product launches, drug innovation, technological advancements andgrowth in the development of biologics.
- Advertising -
North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024 from USD 501.37 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024.
North America Drug Delivery Market,By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical (Formulations, Transdermal Devices), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Centers, Others), By Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, Online Pharmacies), By Country (U.S., Canada, Mexico) – Trends and Forecast to 2024
The North America Drug Delivery Market is segmented on the basis of route of administration, end users, and region.
On the basis of route of administration the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug.
- Advertising -
Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=north-america-drug-delivery-market-trends-forecast24
On the basis of distribution channel the North America drug delivery market is segmented into hospital pharmacies, pharmacy stores,
direct tenders and online pharmacy. In 2017, the direct tenders segment is expected to dominate the market.
On the basis of end users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others. The hospitals segment dominates the North America drug delivery market with more than 40.0% market share.
On the basis of applications, the market is segmented into medical imaging, dental imaging, security, veterinary and, industrial. The medical imaging application is further sub segmented into static imaging (general radiography and mammography) and dynamic imaging (general fluoroscopy, surgical imaging, and cardiovascular imaging).
Browse Full Report with Details TOC databridgemarketresearch.com/repor…ds-forecast-2024/
On the basis of end users the market is segmented into hospitals, gynecology clinics, and community healthcare.
Based on North America, the market is segmented into geographical regions:
Some of the major players operating in this market are
- Hoffmann-La Roche AG
- Pfizer, Inc.
- GlaxoSmithKline plc.
- Merck & Co., Sanofi
- Antares Pharma
- 3M, Becton Dickinson and Company
- Nemera, Cima Labs, Inc.
- ali Medical Devices
- Skyepharma AG
- Valeant Pharmaceuticals DSM Biomedical
- Catalent, Inc
Inquiry before Access @ databridgemarketresearch.com/inqui…trends-forecast24
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: